217 related articles for article (PubMed ID: 23079743)
21. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats.
Chen W; Fan D; Meng L; Miao Y; Yang S; Weng Y; He H; Tang X
Drug Dev Ind Pharm; 2012 Jan; 38(1):104-10. PubMed ID: 21774632
[TBL] [Abstract][Full Text] [Related]
22. Acute toxicity of berberine and its correlation with the blood concentration in mice.
Kheir MM; Wang Y; Hua L; Hu J; Li L; Lei F; Du L
Food Chem Toxicol; 2010 Apr; 48(4):1105-10. PubMed ID: 20138204
[TBL] [Abstract][Full Text] [Related]
23. Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine.
Wang T; Wang N; Song H; Xi X; Wang J; Hao A; Li T
Eur J Pharm Sci; 2011 Sep; 44(1-2):127-35. PubMed ID: 21742030
[TBL] [Abstract][Full Text] [Related]
24. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
25. Berberine acutely inhibits the digestion of maltose in the intestine.
Li ZQ; Zuo DY; Qie XD; Qi H; Zhao MQ; Wu YL
J Ethnopharmacol; 2012 Jul; 142(2):474-80. PubMed ID: 22626925
[TBL] [Abstract][Full Text] [Related]
26. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.
Li YH; Li Y; Yang P; Kong WJ; You XF; Ren G; Deng HB; Wang YM; Wang YX; Jiang JD; Song DQ
Bioorg Med Chem; 2010 Sep; 18(17):6422-8. PubMed ID: 20673726
[TBL] [Abstract][Full Text] [Related]
28. Combination of simvastatin with berberine improves the lipid-lowering efficacy.
Kong WJ; Wei J; Zuo ZY; Wang YM; Song DQ; You XF; Zhao LX; Pan HN; Jiang JD
Metabolism; 2008 Aug; 57(8):1029-37. PubMed ID: 18640378
[TBL] [Abstract][Full Text] [Related]
29. MgAl monolayer hydrotalcite increases the hypoglycemic effect of berberine by enhancing its oral bioavailability.
Wang A; Yang W; Yang X; Mei X; Hu T; Liang R; Meng D; Yan D
Biomed Pharmacother; 2020 Jul; 127():110140. PubMed ID: 32380387
[TBL] [Abstract][Full Text] [Related]
30. Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity.
Zhang YT; Yu YQ; Yan XX; Wang WJ; Tian XT; Wang L; Zhu WL; Gong LK; Pan GY
Acta Pharmacol Sin; 2019 Jan; 40(1):133-142. PubMed ID: 30442987
[TBL] [Abstract][Full Text] [Related]
31. Research progress on berberine with a special focus on its oral bioavailability.
Liu CS; Zheng YR; Zhang YF; Long XY
Fitoterapia; 2016 Mar; 109():274-82. PubMed ID: 26851175
[TBL] [Abstract][Full Text] [Related]
32. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
[TBL] [Abstract][Full Text] [Related]
33. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways.
Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z
Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788
[TBL] [Abstract][Full Text] [Related]
34. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose.
Liu W; Liu P; Tao S; Deng Y; Li X; Lan T; Zhang X; Guo F; Huang W; Chen F; Huang H; Zhou SF
Arch Biochem Biophys; 2008 Jul; 475(2):128-34. PubMed ID: 18471986
[TBL] [Abstract][Full Text] [Related]
35. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats.
Chen W; Miao YQ; Fan DJ; Yang SS; Lin X; Meng LK; Tang X
AAPS PharmSciTech; 2011 Jun; 12(2):705-11. PubMed ID: 21637946
[TBL] [Abstract][Full Text] [Related]
36. Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis.
Wu YS; Chen YT; Bao YT; Li ZM; Zhou XJ; He JN; Dai SJ; Li CY
PLoS One; 2016; 11(11):e0166378. PubMed ID: 27846294
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study of pharmacokinetics and tissue distribution of 8-cetylberberine and berberine in rats].
Hu YL; Chen C; Zou ZY; Li XG; Ye XL
Yao Xue Xue Bao; 2014 Nov; 49(11):1582-7. PubMed ID: 25757286
[TBL] [Abstract][Full Text] [Related]
38. The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.
Sun R; Kong B; Yang N; Cao B; Feng D; Yu X; Ge C; Feng S; Fei F; Huang J; Lu Z; Xie Y; Yang CS; Guo GL; Wang G; Aa J
Drug Metab Dispos; 2021 Mar; 49(3):276-286. PubMed ID: 33376148
[TBL] [Abstract][Full Text] [Related]
39. Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved?
Yu S; Yu Y; Liu L; Wang X; Lu S; Liang Y; Liu X; Xie L; Wang G
Planta Med; 2010 Jun; 76(9):876-81. PubMed ID: 20108175
[TBL] [Abstract][Full Text] [Related]
40. A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats.
Gu JJ; Gao FY; Zhao TY
J Physiol Pharmacol; 2012 Oct; 63(5):505-13. PubMed ID: 23211304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
